Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2026)
Qiagen (QGEN) recorded Net Income towards Common Stockholders of $103.4 million in the quarter ended Jun 30, 2026, up 7.4% from $96.25 million a year earlier and up 52.0% from the prior quarter.
Powered by 
Analysis
Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Qiagen's Net Income towards Common Stockholders came in at $409.32 million as of Jun 30, 2026, up 9.6% year-over-year; for the year ended Dec 31, 2025, it was $424.88 million.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 3.4% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Net Income towards Common Stockholders came in at -$103 million in the year ended Dec 31, 2024, $341.3 million in the year ended Dec 31, 2023 (-19.4%), $423.21 million in the year ended Dec 31, 2022 (+37.4%) and $308 million in the year ended Dec 31, 2021 (-14.3%).
- Quarterly Net Income towards Common Stockholders has ranged from $68.04 million in the quarter ended Mar 31, 2026 to $155.31 million in the quarter ended Mar 31, 2022 over the past five years.
- On a year-over-year basis, Net Income towards Common Stockholders rose in five of the last eight quarters, with growth averaging 5.5%.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 687.3% in the quarter ended Sep 30, 2021, against a decline of 45.2% in the quarter ended Mar 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $68.04 million (quarter ended Mar 31, 2026), $107.83 million (quarter ended Dec 31, 2025) and $130.04 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 818.10 Mn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 1.28 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 907.00 Mn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 377.00 Mn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 241.90 Mn |
| 10 | Qiagen | 9.76 Bn | 5.53 Bn | 340.39 Mn | 103.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.40 Mn |
| Mar 31, 2026 | 68.04 Mn |
| Dec 31, 2025 | 107.83 Mn |
| Sep 30, 2025 | 130.04 Mn |
| Jun 30, 2025 | 96.25 Mn |
| Mar 31, 2025 | 90.76 Mn |
| Dec 31, 2024 | 88.32 Mn |
| Sep 30, 2024 | 98.06 Mn |
| Jun 30, 2024 | 123.00 Mn |
| Mar 31, 2024 | 80.67 Mn |
| Dec 31, 2023 | 97.66 Mn |
| Sep 30, 2023 | 77.82 Mn |
| Jun 30, 2023 | 80.79 Mn |
| Mar 31, 2023 | 85.04 Mn |
| Dec 31, 2022 | 88.84 Mn |
| Sep 30, 2022 | 82.39 Mn |
| Jun 30, 2022 | 96.66 Mn |
| Mar 31, 2022 | 155.31 Mn |
| Dec 31, 2021 | 129.19 Mn |
| Sep 30, 2021 | 133.14 Mn |
API Access
Qiagen Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=QGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "QGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=QGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();